Arbutus Biopharma (ABUS) Finished Goods (2010)

Arbutus Biopharma (ABUS) posted Finished Goods of $148751.7 for Q4 2010.

Arbutus Biopharma (ABUS) Finished Goods (2010) Analysis & Trends

Arbutus Biopharma has reported Finished Goods for 1 years, with the latest figure at $148751.7 in Q4 2010.

Quarterly Finished Goods changed N/A year-over-year to $148751.7 in Q4 2010, while the trailing twelve-month figure through Dec 2010 was $148751.7 (changed N/A YoY) and the FY2010 annual result came in at $148751.7, changed N/A from the prior year.
Finished Goods was little changed at $148751.7 in Q4 2010 per ABUS's latest filing.
Over five years, Finished Goods peaked at $148751.7 in Q4 2010 and troughed at $148751.7 in Q4 2010.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Arbutus Biopharma	922.95 Mn	830.33 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2010	148,751.65